Head & Professor,
Department of Pharmacy
Finding Agency |
Project Title |
Approved Fund |
Duration |
DST SERB-CRG |
Therapeutic potential of endogenous peptides in hypertension |
36 Lakhs |
2021-2024 |
ICMR |
Role of novel endogenous peptides in cardiometabolic disorders |
29 Lakhs |
2021-2024 |
ICMR |
Therapeutic potential of novel MAD2 inhibitors in ovarian cancer |
35 Lakhs |
2022-2025 |
ISSAR Pharmaceuticals |
Pre-Clinical Efficacy Evaluation of synthetic Peptides For the Treatment of Inflammatory Bowel Disease & Sepsis |
29 Lakhs |
2020-2023 |
Department of Science and Technology (DST) and SERB Under Young Scientist Scheme) |
Role of double stranded RNA dependent protein kinase (PKR) in hypertension: Mechanism and prevention |
27 Lakhs |
2015-2018 |
CSIR |
Pharmacological evaluation of novel double stranded RNA dependent protein kinase (PKR) inhibitors for diabetic cardiomyopathy”.
|
24 Lakhs |
2015-2018 |
BITS (Under additional Competitive grant) |
Evaluation of novel pharmacological agents targeted at methylglyoxal in diabetic cardiomyopathy |
10 Lakhs |
2015-2017 |
UGC |
Evaluation of pharmacological agents targeted at double stranded RNA dependent protein kinase (PKR) in type 2 diabetes mellitus |
6 Lakhs |
2014-2016 |
BITS (Research Initiation Grant) |
Role of methyglyoxal in diabetic cardiomyopathy |
2 Lakhs |
2014-2016 |
This website uses cookies or similar technologies, to enhance your browsing experience.